t-10

Tripeptide-10 citrulline(T10-C)，一种生物活性肽，具备抗衰老(anti-aging)功能，广泛应用于化妆品成分。

Dextran T10 (MW 10,000)是一种平均分子量为 10000 的脱水葡萄糖聚合物。它具有优良的生物降解性和生物相容性，广泛应用于食品、药品、化妆品和研究领域。

ABT-100 is a potent, highly selective, and orally active farnesyl transferase inhibitor with broad-spectrum antitumor activity.

ST-1006是一种强效组胺 H4受体激动剂（pKi：7.94）。ST-1006具有抗炎作用。ST-1006是一种有效的嗜碱性粒细胞迁移诱导剂，可诱导嗜碱性粒细胞迁移。 ST-1006 具有抗炎作用和止痒作用。

MRT 10 是一种七跨膜平滑受体 (Smo) 拮抗剂，通过多种 Hedgehog (Hh) 测定，其IC50=0.65 μM。它与Smo 受体结合的位点是 Bodipycyclopamine。它可用于研究癌症。

CORT-108297 Enantiomer 是 CORT-108297 的对映体，CORT-108297是糖皮质激素受体的拮抗剂。

CYT-1010 is an mu-opioid receptor agonist. The EC50 for the inhibition of β-arrestin recruitment and cAMP production is 13.1 nM and 0.0053 nM, respectively.

CYT-1010 hydrochloride is an mu-opioid receptor agonist. The EC50 for β-arrestin recruitment and cAMP production inhibition were 13.1 nM and 0.0053 nM, respectively.

AT-1002 is a tight junction regulator and absorption enhancer. It is a 6-mer synthetic peptide.

AT-1002 TFA is a tight junction regulator and absorption enhancer. It is a 6-mer synthetic peptide.

CVT-10216 是可逆的、选择性的醛脱氢酶 2（ALDH-2）抑制剂，IC50为 29 nM。对 ALDH-1的抑制作用较弱，IC50为 1.3 μM。 它可以减少偏爱酒精的大鼠过量饮酒，并表现出抗焦虑作用。

Anti-osteoporosis agent-10 作为一种有效的骨质疏松抑制剂，其通过抑制破骨细胞的生成发挥作用，其IC50为0.042 μM。此外，该化合物对PPARγ亦展示了拮抗活性，具体的EC50为0.75 μM。

Antimycobacterial agent-10 (compound 5) 是一种 DNA 旋转酶的抑制剂（IC50=96 nM，结核分枝杆菌旋转酶），并具有抗菌活性。

T-10430 是一种具有口服活性的有效白三烯 B4 受体 2 (leukotriene B4 receptor 2 (BLT2)) 激动剂，具有用于银屑病研究的潜力。

ZQMT-10 是一种口服活性的 TRPA1 抑制剂，Kd 为 1.04 μM，并在癌症研究中具有重要作用。

BMT-108908 is a Negative Allosteric Modulator. It is selective for the NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains.

NCT-10b is a selective inhibitor of HDAC6.

T-1095A is an active metabolite of T-1095, a potent and selective inhibitor of Na+-glucose cotransporters (SGLTs). Chronic administration of T-1095 (0.1% w w(-1) pellet chow, for 12 weeks) decreased blood glucose and haemoglobin A(1C) levels, and improved

PBT-1033 hydrochloride is a potential neuroprotective agent for the treatment of Alzheimer's disease and Huntington's disease.

ACT-1004-1239 是一种可口服且具有选择性和高效性的 CXCR7 拮抗剂，具有免疫调节和髓鞘促生作用，用于研究炎性脱髓鞘疾病。

Antitubercular agent-10 shows potent antitubercular activity with a MIC value of 30 nM.

ABT-107, a selective α7 neuronal nicotinic receptor agonist, demonstrates neuroprotective effects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions.

Antiparasitic agent-10 (Compound 94) is a potent anti-parasitic agent specifically designed to target and combat parasitic infections. It demonstrates notable anti-schistosomal activity, particularly against adults of Schistosoma mansoni. As a result, this compound holds significant potential for utilization in Schistosomiasis research as a viable treatment option [1].

Antileishmanial agent-10 (Compound 7h) 是一种抗原虫 (antiprotozoal) 剂。